An Exploration of Genetic Testing for Prostate Cancer Susceptibility

Recruiting

You are on the General Public view
  • Source

    -
    Public Title An Exploration of Genetic Testing for Prostate Cancer Susceptibility
    Acronym Sorry, not currently available
    Source of Record URL http://clinicaltrials.gov/show/NCT00997464
  • Trial

    -
    Health Condition(s) or Problem Prostate Cancer
    Lay Summary Study of the factors that affect interest in - and uptake of - genetic testing for variants that predispose to prostate cancer from the perspective of the patient. (from ClinicalTrials.gov)
    Who can enter the trial Inclusion Criteria: - Men with a positive family history of prostate cancer. The definition of a positive family history will be: Men with a first degree relative with prostate cancer diagnosed at <70 years; Men with two relatives with prostate cancer where at least on is diagnosed at <70 years; Men with three relatives with prostate cancer diagnosed at any age - Age 40-69 years - No previous biopsy for raised PSA - Absence of any psychological, familial, sociological or geographic situation potentially hampering compliance with the study protocol and follow-up schedule. Exclusion Criteria: - Previous prostate cancer - Men from families where there is known to be a mutation in a high-risk prostate cancer gene - Men who have had a prostate biopsy within the last 12 months.
    Who cannot enter the trial Inclusion Criteria: - Men with a positive family history of prostate cancer. The definition of a positive family history will be: Men with a first degree relative with prostate cancer diagnosed at <70 years; Men with two relatives with prostate cancer where at least on is diagnosed at <70 years; Men with three relatives with prostate cancer diagnosed at any age - Age 40-69 years - No previous biopsy for raised PSA - Absence of any psychological, familial, sociological or geographic situation potentially hampering compliance with the study protocol and follow-up schedule. Exclusion Criteria: - Previous prostate cancer - Men from families where there is known to be a mutation in a high-risk prostate cancer gene - Men who have had a prostate biopsy within the last 12 months.
    What will happen Sorry, not currently available
    Primary aim Whether cancer worry changes between the two time-points (measured using the Impact of Event Scale)
    Secondary Aim Why are men interested/ not interested in seeking genetic profiling for prostate cancer, and what might be the uptake of such testing?; No; What are the expectations of this testing from the perspective of the user, what are the perceived benefits and limitations of testing and how do these change through the testing process; No; Is there a relationship between a family history of cancer, cancer worry, and a persons intention to seek genetic testing?; No; How would the information provided by such a test be used by the individual and the family and how could this impact upon the healthcare system; No
    Participant Information Sheet Sorry, not currently available
    Website Sorry, not currently available
    Recruitment Status Recruiting
    Nation England
    Location Sutton
  • Contact

    -
    Contact for Public Queries Dr Rosalind Eeles 02086613642 rosalind.eeles@icr.ac.uk Dr Rosalind Eeles Principal Investigator Institute of Cancer Research, United Kingdom
    Contact for Scientific Queries Sorry, not currently available
Please note:
  1. The UKCTG information is designed to inform you of existing trials. If you wish to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.
  2. The UKCTG is not responsible for the quality of the data displayed in the Gateway but can contact the data providers. Please contact us if you have any query regarding the quality of trial records.